NK

Nasar Kuchanath House

Active Director Director DIN 08013283
DIN 08013283 First appointment Dec 2017 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Nasar Kuchanath House

Data last updated:

Nasar Kuchanath House is a Director at Agueda Pharmaceuticals Private Limited (since 2017). The company operates in Business Services.

DIN 08013283
Primary Designation Director
Industry Business Services
First Appointment 06 Dec 2017
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Dec 20172017Active

Directorship timeline

Open interactive timeline →
Agueda Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Nasar Kuchanath House

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nasar Kuchanath House

Nasar Kuchanath House currently holds 1 directorship: Agueda Pharmaceuticals Private Limited (Director, since 06 Dec 2017).

Nasar Kuchanath House was first appointed on 06 Dec 2017 as Director at Agueda Pharmaceuticals Private Limited.

The current boards of Nasar Kuchanath House's companies include Anirudhan Kadamkuni (Agueda Pharmaceuticals Private Limited), Ganesh Babu Kizhake Veetil (Agueda Pharmaceuticals Private Limited), Jayan Karthanam Veedu (Agueda Pharmaceuticals Private Limited), Sreevidya Poyil Narayanan (Agueda Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available